EP3535300
ACTIVATABLE ANTI-CTLA-4 ANTIBODIES AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.11.2017EP published:
22.10.2025EP application number:
17837917.8
EPO information:
European Patent Register
Max expiry date:
1.11.2037
Title in English:
ACTIVATABLE ANTI-CTLA-4 ANTIBODIES AND USES THEREOFLanguage of the patent:
English
Timeline
Today
2.11.2017EP application
22.10.2025EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Name:
CytomX Therapeutics, Inc.Address:
151 Oyster Point Boulevard Suite 400, South San Francisco, California 94080, US
Inventor
Name:
TIPTON, Kimberly AnnAddress:
South San Francisco, California 94080, US
Name:
WEST, James WilliamAddress:
South San Francisco, California 94080, US
Name:
DESHPANDE, ShrikantAddress:
Redwood City, California 94063, US
Name:
ENGELHARDT, John J.Address:
Redwood City, California 94063, US
Priority
Number:
201662417212 PDate:
3.11.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, C12N 15/13, C12N 15/62, C07K 19/00, A61P 35/00